JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Emile Bacha
Richard A. Jonas
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jahangiri, M.
Right arrow Articles by Jonas, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jahangiri, M.
Right arrow Articles by Jonas, R. A.

J Thorac Cardiovasc Surg 2000;120:778-782
© 2000 The American Association for Thoracic Surgery


Surgery for Congenital Heart Disease

Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation

Marjan Jahangiri, FRCS, Jacqueline Kreutzer, MD, David Zurakowski, PhD, Emile Bacha, MD, Richard A. Jonas, MD

From the Department of Cardiology and Cardiac Surgery, Children's Hospital, Boston, Mass.

Address for reprints: Richard A. Jonas, MD, Department of Cardiac Surgery, Children's Hospital, 300 Longwood Ave, Boston, MA 02115.

Objective: Low-velocity and nonlaminar flow patterns in the Fontan circulation, as well as abnormal liver function in some patients, may partly account for the coagulation abnormalities seen. We examined (1) coagulation factor abnormalities before and after the Fontan procedure and (2) regional coagulation factor abnormalities in the Fontan circulation.
Methods: Levels of factors V, VII, VIII, X, antithrombin III, prothrombin fragment F1+2, protein C, and protein S were measured in 2 groups of patients: In 14 patients undergoing the Fontan procedure, blood was analyzed before the operation and 5 days after the operation (group 1). The median age in this group was 3.2 years. In 10 patients who had undergone the Fontan procedure, cardiac catheterization was performed and samples were taken from the femoral vein, inferior vena cava, right atrium, and pulmonary artery (group 2). The median age in this group was 6.2 years and the median follow-up from the Fontan procedure was 4.1 years.
Results: In group 1 a significant increase was noted postoperatively in the concentration of factor VIII (P < .001), factor X (P < .001), and prothrombin fraction F1+2 (P < .001). A significant decrease in the levels of antithrombin III (P < .001), protein C (P < .004), and protein S (P < .02) was also found. The increase in factors VIII and X persisted at 4 years' follow-up in group 2 patients. In group 2, no significant regional differences were observed between the coagulation factors measured at different sites.
Conclusions: There is an increased tendency toward coagulation after the Fontan procedure. A prothrombotic state is supported by thrombin generation associated with reduced antithrombin III concentration. This increase in coagulation may contribute to the early and late risks of thromboembolism observed after the Fontan procedure. We did not find any regional differences in coagulation abnormalities in patients late after the Fontan procedure. Therefore, the mechanisms and causes of the coagulation abnormalities remain unclear.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. C. Odegard, D. Zurakowski, J. A. DiNardo, R. A. Castro, F. X. McGowan Jr., E. J. Neufeld, and P. C. Laussen
Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion
J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 934 - 941.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Camposilvan, O. Milanesi, G. Stellin, A. Pettenazzo, L. Zancan, and L. D'Antiga
Liver and Cardiac Function in the Long Term After Fontan Operation
Ann. Thorac. Surg., July 1, 2008; 86(1): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Cholette, J. S. Rubenstein, G. M. Alfieris, M. P. McDermott, W. G. Harmon, R. Vermilion, M. P. Eaton, J. J. Gangemi, and N. B. Lerner
Elevated Risk of Thrombosis in Neonates Undergoing Initial Palliative Cardiac Surgery
Ann. Thorac. Surg., October 1, 2007; 84(4): 1320 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Procelewska, J. Kolcz, K. Januszewska, T. Mroczek, and E. Malec
Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures -- the importance of hemodynamics in the early postoperative period
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 866 - 872.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. C. Odegard, D. Zurakowski, S. Hornykewycz, J. A. DiNardo, R. A. Castro, E. J. Neufeld, and P. C. Laussen
Evaluation of the Coagulation System in Children with Two-Ventricle Congenital Heart Disease
Ann. Thorac. Surg., May 1, 2007; 83(5): 1797 - 1803.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H A Walker and M A Gatzoulis
Prophylactic anticoagulation following the Fontan operation
Heart, July 1, 2005; 91(7): 854 - 856.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. L. Jacobs
The Fontan operation, thromboembolism, and anticoagulation: A reappraisal of the single bullet theory
J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 491 - 495.
[Full Text] [PDF]


Home page
HeartHome page
V Chaloupecky, I Svobodova, I Hadacova, V Tomek, B Hucin, T Tlaskal, J Janousek, O Reich, and J Skovranek
Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up
Heart, January 1, 2005; 91(1): 73 - 79.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. T. Lovell
Anaesthetic implications of grown-up congenital heart disease
Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Nakano, H. Kado, S. Ishikawa, Y. Shiokawa, H. Ushinohama, K. Sagawa, N. Fusazaki, Y. Nishimura, Y. Tanoue, T. Nakamura, et al.
Midterm surgical results of total cavopulmonary connection: clinical advantages of the extracardiac conduit method
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 730 - 737.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. C. Odegard, F. X. McGowan Jr, D. Zurakowski, J. A. DiNardo, R. A. Castro, P. J. del Nido, and P. C. Laussen
Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: Increased factor VIII may predispose to thrombosis
J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1260 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. K. Woods, U. Dyamenahalli, B. W. Duncan, G. L. Rosenthal, and F. M. Lupinetti
Comparison of extracardiac Fontan techniques: Pedicled pericardial tunnel versus conduit reconstruction
J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Setty, K. Finucane, J. R. Skinner, and A. R. Kerr
Extracardiac conduit with a limited maze procedure for the failing Fontan with atrial tachycardias
Ann. Thorac. Surg., December 1, 2002; 74(6): 1992 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. G. Seipelt, A. Franke, J. F. Vazquez-Jimenez, P. Hanrath, G. von Bernuth, B. J. Messmer, and E. G. Muhler
Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches
Ann. Thorac. Surg., August 1, 2002; 74(2): 556 - 562.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. K. Triedman, M. E. Alexander, B. A. Love, K. K. Collins, C. I. Berul, L. M. Bevilacqua, and E. P. Walsh
Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1827 - 1835.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. C. Odegard, F. X. McGowan Jr, D. Zurakowski, J. A. DiNardo, R. A. Castro, P. J. del Nido, and P. C. Laussen
Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the fontan procedure
Ann. Thorac. Surg., June 1, 2002; 73(6): 1770 - 1777.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. C. Odegard, F. X. McGowan Jr, J. A. DiNardo, R. A. Castro, D. Zurakowski, C. M. Connor, D. D. Hansen, E. J. Neufeld, P. J. del Nido, and P. C. Laussen
Coagulation abnormalities in patients with single-ventricle physiology precede the Fontan procedure
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 459 - 465.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. L. Jacobs, K. K. Pourmoghadam, E. M. Geary, A. T. Reyes, N. Madan, L. B. McGrath, and J. W. Moore
Fontan's operation: is aspirin enough? Is coumadin too much?
Ann. Thorac. Surg., January 1, 2002; 73(1): 64 - 68.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The American Association for Thoracic Surgery.